Evaluation of synergistic effects of resynchronization therapy and a β-blocker up-titration strategy based on a predefined patient-management program: the RESTORE study. (Q51018457)

From Wikidata

Jump to navigation Jump to search

scientific article published on 7 January 2015

Language	Label	Description	Also known as
English	Evaluation of synergistic effects of resynchronization therapy and a β-blocker up-titration strategy based on a predefined patient-management program: the RESTORE study.	scientific article published on 7 January 2015

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/25580847

Evaluation of synergistic effects of resynchronization therapy and a β-blocker up-titration strategy based on a predefined patient-management program: the RESTORE study (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6711010&resulttype=core&format=json

12 May 2020

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6711010&resulttype=core&format=json

12 May 2020

Antonio Rapacciuolo

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6711010&resulttype=core&format=json

12 May 2020

Sergio Valsecchi

11

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6711010&resulttype=core&format=json

12 May 2020

Antonio D'Onofrio

3

object named as

Antonio D'Onofrio

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6711010&resulttype=core&format=json

12 May 2020

author name string

Pietro Palmisano

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6711010&resulttype=core&format=json

12 May 2020

Ernesto Ammendola

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6711010&resulttype=core&format=json

12 May 2020

Michele Accogli

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6711010&resulttype=core&format=json

12 May 2020

Antonio Ruocco

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6711010&resulttype=core&format=json

12 May 2020

Giuseppe Del Giorno

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6711010&resulttype=core&format=json

12 May 2020

Valter Bianchi

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6711010&resulttype=core&format=json

12 May 2020

Maurizio Malacrida

10

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6711010&resulttype=core&format=json

12 May 2020

Edoardo Gronda

12

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6711010&resulttype=core&format=json

12 May 2020

publication date

7 January 2015

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/25580847

Clinical Cardiology

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6711010&resulttype=core&format=json

12 May 2020

38

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6711010&resulttype=core&format=json

12 May 2020

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6711010&resulttype=core&format=json

12 May 2020

2-7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6711010&resulttype=core&format=json

12 May 2020

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22352

21 January 2018

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22352

21 January 2018

Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22352

21 January 2018

Effect of carvedilol on survival in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22352

21 January 2018

Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22352

21 January 2018

The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22352

21 January 2018

Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE).

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22352

21 January 2018

The use of beta-blockers in a tertiary care heart failure clinic: dosing, tolerance, and outcomes

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22352

21 January 2018

Heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22352

21 January 2018

Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22352

21 January 2018

Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22352

21 January 2018

Cardiac-resynchronization therapy for the prevention of heart-failure events

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22352

21 January 2018

Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22352

21 January 2018

The effect of cardiac resynchronization on morbidity and mortality in heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22352

21 January 2018

The efficacy and safety of cardiac resynchronization therapy combined with implantable cardioverter defibrillator for heart failure: a meta-analysis of 5674 patients

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22352

21 January 2018

Underutilization of beta-blockers in patients undergoing implantable cardioverter-defibrillator and cardiac resynchronization procedures.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22352

21 January 2018

Beta-blocker utilization and outcomes in patients receiving cardiac resynchronization therapy.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22352

21 January 2018

Comparison of medical therapy dosing in outpatients cared for in cardiology practices with heart failure and reduced ejection fraction with and without device therapy: report from IMPROVE HF.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22352

21 January 2018

Use of cardiac resynchronization therapy to optimize beta-blocker therapy in patients with heart failure and prolonged QRS duration

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22352

21 January 2018

2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Associ

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22352

21 January 2018

Predictors of left ventricular reverse remodeling after cardiac resynchronization therapy for heart failure secondary to idiopathic dilated or ischemic cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22352

21 January 2018

Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22352

21 January 2018

Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure: analysis of the experience in metoprolol CR/XL randomized intervention trial in chronic heart failure (MERIT-HF).

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22352

21 January 2018

Bisoprolol dose-response relationship in patients with congestive heart failure: a subgroup analysis in the cardiac insufficiency bisoprolol study(CIBIS II).

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22352

21 January 2018

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22352

21 January 2018

Patterns of beta-blocker utilization in patients with chronic heart failure: experience from a specialized outpatient heart failure clinic

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22352

21 January 2018

beta-adrenergic receptor blockade in chronic heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22352

21 January 2018

Remote titration of carvedilol for heart failure patients by advanced practice nurses

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22352

21 January 2018

Treatment with beta-blockers in nurse-led heart failure clinics: titration efficacy and predictors of failure.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22352

21 January 2018

Impact of telemonitoring at home on the management of elderly patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22352

21 January 2018

Rapid titration of carvedilol in patients with congestive heart failure: a randomized trial of automated telemedicine versus frequent outpatient clinic visits.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22352

21 January 2018

Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22352

21 January 2018

Nurse-Led Titration of β-Adrenoreceptor Blocking Agents in Chronic Heart Failure Patients in the Community

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22352

21 January 2018

Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22352

7 January 2021

based on heuristic

inferred from DOI database lookup

CArdiac resynchronization in combination with beta blocker treatment in advanced chronic heart failure (CARIBE-HF): the results of the CARIBE-HF study.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22352

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-response of chronic beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Bucindolol Investigators

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22352

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential effects of beta-blockers in patients with heart failure: A prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22352

7 January 2021

based on heuristic

inferred from DOI database lookup

The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/25580847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A rationale for the use of beta-blockers as standard treatment for heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/25580847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of β-adrenergic blockade on left ventricular remodeling among Hispanics and African Americans with chronic heart failure.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25580847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/25580847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Practical guidelines for initiation of beta-adrenergic blockade in patients with chronic heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/25580847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/CLC.22352

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6711010&resulttype=core&format=json

12 May 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6711010&resulttype=core&format=json

12 May 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6711010&resulttype=core&format=json

12 May 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51018457&oldid=1576580562"